Merck Escapes High Court Hearing In $26M Vioxx Suit
The U.S. Supreme Court declined Monday to consider whether a Texas appeals court erred in tossing a $26.1 million Vioxx liability verdict against Merck & Co. Inc., allowing the pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article